Novel insights into healthy humans’ faecal carriage of enterococci: Enterococcus lactis is as a dominant highly bacteriocinogenic species
DOI:
https://doi.org/10.48797/sl.2023.51Keywords:
Selected Oral CommunicationAbstract
Background: Enterococcus lactis (Elts) [former Enterococcus faecium (Efm) clade-B] has been greatly associated with human colonization, but its epidemiology is unknown since this reclassification [1]. We aimed to assess the contemporary faecal carriage of enterococci species among healthy-humans (HH) in Portugal and get novel insights about Efm/Elts differences. Methods: Fifty-one faecal samples (29-women/22-men;18-85/~45-years) from HH in Northern Portugal (February-July 2022) were processed by enrichment/selection steps with/without ampicillin, vancomycin or linezolid. Efm, Elts and other species were identified by PCR [2, 3] and antibiotic-susceptibility by disk-diffusion/broth-microdilution (EUCAST/CLSI). Representatives/sample (n=40) were characterized by Whole-Genome-Sequencing/CGE-tools, including a homemade bacteriocins(bac) database. Qualitative bacteriocin production/sensitivity was performed in sequenced Efm/Elts and selected clinical VREfm (vancomycin-resistant-Efm) and Elts (all-against-all) using the soft-agar-overlay technique. Results: All samples carried Enterococcus (n=337), with most containing Elts-73% (p<0.05) and/or E.faecalis (Efs)-61% and variable occurrence for Efm-45%, E.hirae-16%, and/or other species (<2%). Samples (24% multidrug-resistant) included isolates resistant to erythromycin [73%;erm(B)/msr(C)], tetracycline [63%;tet(M)/tet(L)], high-level-streptomycin (22%;ant(6)-Ia/str), chloramphenicol (12%;cat/fexA/fexB/optrA/poxtA), quinupristin-dalfopristin (12%), high-level-gentamycin [4%;aac(6’)-Ie-aph(2’’)-Ia] and linezolid (4%-optrA/poxtA;MIC50/MIC90 4-mg/L). Acquired linezolid-resistance genes were detected in two samples: optrA (one E. thailandicus; MIC=8-mg/L) and optrA+poxtA (ST128-Efm; MIC=8-16-mg/L). Typical bacteriocins and plasmids from clinical Efm/Efs were scarce. Elts (2-5 bac; 100%-bac-genes+) and Efm (0-9; 71%-bac+) shared bacteriocins (e.g.,entP/entQ) contrasting with others exclusive of Efs (0-2;22%-bac+). No isolate could inhibit all or be inhibited by all, but the ones with more bacteriocins were less inhibited. Most Efm/Elts showed no activity against each other but ~30%/each inhibited most strains tested, including VREfm. Conclusions: Elts is one predominant enterococci gut species that would be misidentified as Efm without an accurate Efm/Elts distinction. Elts co-exist with Efm in the intestine, but specific Efm/Elts inhibiting most strains tested may contribute to microbiota restoration after antibiotic treatments. Linezolid-resistance genes finding is worrisome, suggesting an environmental/food-chain role in this acquisition since they were not described in enterococci from Portuguese hospitals before.
References
1. Belloso Daza, M.V., C. Cortimiglia, et al., Genome-based studies indicate that the Enterococcus faecium Clade B strains belong to Enterococcus lactis species and lack of the hospital infection associated markers. Int J Syst Evol Microbiol, 2021. 71(8).
2. Belloso Daza, M.V., A.C. Almeida-Santos, et al., Distinction between Enterococcus faecium and Enterococcus lactis by a gluP PCR-Based Assay for Accurate Identification and Diagnostics. Microbiol Spectr, 2022. 10(6): p. e0326822.
3. Jackson, C.R., P.J. Fedorka-Cray, and J.B. Barrett, Use of a genus- and species-specific multiplex PCR for identification of enterococci. J Clin Microbiol, 2004. 42(8): p. 3558-65.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 A. C. Almeida-Santos, B. Duarte, M. J. Teixeira, A. P. Tedim, C. Novais, L. Peixe, A. R. Freitas
This work is licensed under a Creative Commons Attribution 4.0 International License.
In Scientific Letters, articles are published under a CC-BY license (Creative Commons Attribution 4.0 International License), the most open license available. The users can share (copy and redistribute the material in any medium or format) and adapt (remix, transform, and build upon the material for any purpose, even commercially), as long as they give appropriate credit, provide a link to the license, and indicate if changes were made (read the full text of the license terms and conditions of use).
The author is the owner of the copyright.